森萱医药
(920946)
| 流通市值：46.05亿 | | | 总市值：46.06亿 |
| 流通股本：4.27亿 | | | 总股本：4.27亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 411,214,920.81 | 260,780,605.31 | 125,565,724.8 | 537,136,066.43 |
| 营业收入 | 411,214,920.81 | 260,780,605.31 | 125,565,724.8 | 537,136,066.43 |
| 二、营业总成本 | 282,805,255.69 | 177,772,448.45 | 89,563,161.4 | 384,117,079.97 |
| 营业成本 | 217,308,292.91 | 134,210,670.19 | 68,147,644.73 | 303,074,084.84 |
| 税金及附加 | 6,365,195.37 | 4,176,589.47 | 1,910,951.11 | 6,998,284.82 |
| 销售费用 | 10,641,996.05 | 7,289,042.53 | 3,753,124.26 | 14,481,608.19 |
| 管理费用 | 39,967,561.02 | 25,665,750.45 | 13,740,994.41 | 57,542,288 |
| 研发费用 | 19,946,134.85 | 12,297,427.89 | 4,548,782.88 | 28,636,950.09 |
| 财务费用 | -11,423,924.51 | -5,867,032.08 | -2,538,335.99 | -26,616,135.97 |
| 其中:利息费用 | 75,779.73 | 40,920.96 | 11,797.95 | 583,687.08 |
| 其中:利息收入 | 13,004,900.32 | 6,382,420.47 | 2,654,133.72 | 25,244,158.81 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 1,442,640.98 | 854,982.69 | 484,059.14 | 1,464,962.91 |
| 加:投资收益 | 552,182 | 420,272.41 | 48,647.26 | 1,198,523.11 |
| 资产处置收益 | 14,997.57 | 4,478.7 | - | -190,269.32 |
| 资产减值损失(新) | -5,946,841.45 | -4,368,596.75 | -2,424,771.3 | -8,250,382.13 |
| 信用减值损失(新) | 592,690.84 | 981,538 | 638,867.84 | -2,369,004.11 |
| 其他收益 | 1,369,887.16 | 1,090,969.98 | 780,324.46 | 4,978,251.4 |
| 四、营业利润 | 126,435,222.22 | 81,991,801.89 | 35,529,690.8 | 149,851,068.32 |
| 加:营业外收入 | 0.17 | 0.16 | - | 1,600,678.96 |
| 减:营业外支出 | 30,800.35 | 5,640.5 | - | 4,240,098.05 |
| 五、利润总额 | 126,404,422.04 | 81,986,161.55 | 35,529,690.8 | 147,211,649.23 |
| 减:所得税费用 | 18,228,078.36 | 11,947,895.44 | 5,307,652.93 | 21,553,561.59 |
| 六、净利润 | 108,176,343.68 | 70,038,266.11 | 30,222,037.87 | 125,658,087.64 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 108,176,343.68 | 70,038,266.11 | 30,222,037.87 | 125,658,087.64 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 103,656,049.35 | 67,920,072.39 | 29,032,478.96 | 123,759,884.41 |
| 少数股东损益 | 4,520,294.33 | 2,118,193.72 | 1,189,558.91 | 1,898,203.23 |
| 扣除非经常损益后的净利润 | 100,876,271.35 | 66,192,565.89 | 28,283,639.73 | 116,722,626.76 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.24 | 0.16 | 0.07 | 0.29 |
| (二)稀释每股收益 | 0.24 | 0.16 | 0.07 | 0.29 |
| 九、综合收益总额 | 108,176,343.68 | 70,038,266.11 | 30,222,037.87 | 125,658,087.64 |
| 归属于母公司股东的综合收益总额 | 103,656,049.35 | 67,920,072.39 | 29,032,478.96 | 123,759,884.41 |
| 归属于少数股东的综合收益总额 | 4,520,294.33 | 2,118,193.72 | 1,189,558.91 | 1,898,203.23 |
| 公告日期 | 2025-10-29 | 2025-08-29 | 2025-04-29 | 2025-04-14 |
| 审计意见(境内) | | | | 标准无保留意见 |